Table 3.
Fleiss’ kappa results (values and category of agreement)
Parameter | Experts | Participants | ||||||
---|---|---|---|---|---|---|---|---|
Phase 1 | Phase 2 | Phase 1 | Phase 2 | |||||
Function | 0.55 | (moderate) | 0.47 | (moderate) | 0.38 | (fair) | 0.42 | (moderate) |
Perfusion | 0.67 | (substantial) | 0.71 | (substantial) | 0.39 | (fair) | 0.49 | (moderate) |
PHR | 0.41 | (moderate) | 0.41 | (moderate) | 0.33 | (fair) | 0.49 | (moderate) |
TID | 0.41 | (moderate) | 0.34 | (fair) | 0.28 | (fair) | 0.41 | (moderate) |
SDS strat | 0.50 | (moderate) | 0.52 | (moderate) | 0.19 | (slight) | 0.38 | (fair) |
PHR, patient high risk; TID, transient ischemic dilation; SDS strat, stratification of perfusion defects